The Agent-Native Data Moat at Series A vs Series B
How agent-native startups build defensible data moats from Series A to Series B — architecture, feedback loops, and production infrastructure strategy.
THE RECORD BEHIND THE WORK
Operational intelligence, frameworks and evidence—organized as one enduring institutional record.
Every view below is reserved for the complete Field Notes record. Filters, search and article routes remain stable as the archive grows.
How agent-native startups build defensible data moats from Series A to Series B — architecture, feedback loops, and production infrastructure strategy.
Compare the top firms deploying AI agents for commercial lending across underwriting, covenant monitoring, and borrower communication workflows.
How investors evaluate board composition and governance in agent-native companies — what they need before committing capital.
Agent-native demos fail because buyers can't evaluate autonomy in a slide deck. Here's the sales motion that actually closes.
How agent-native companies evolve pricing from project-based to outcome-based—a methodology for building durable, value-aligned revenue models.
Agent-native engineering teams require a fundamentally different org structure than SaaS. Here's the methodology that works.
How AI-assisted clinical recommendations reshape informed consent documentation chains, compliance obligations, and audit-ready workflows for healthcare teams.
A practical methodology for building multi-jurisdiction agent fleets with country-specific permission sets across compliance, data, and infrastructure layers.
How AI agents must handle data residency under GDPR, Saudi PDPL, and India DPDP — architecture, transfer rules, and consent enforcement.
How agents assist medication reconciliation at discharge, where liability sits, and what production infrastructure must deliver for clinical safety.
How AI agents accelerate clinical trial enrollment through real-time patient matching, protocol translation, and automated pre-screening workflows.
How healthcare organizations should evaluate liability when a clinical sepsis alert agent misses a case — governance, architecture, and accountability.
Export controls beyond ITAR shape every cross-border AI agent deployment. Learn how EAR and Wassenaar apply before your next build.
How UK, German, and Australian consumer protection laws apply to AI agents serving customers—and what compliance really demands in practice.
How autonomous agents reshape LTV/CAC ratios by owning subscription renewals and expansion—a methodology guide for operators.
Two frameworks for measuring agent ROI across cost centers and revenue departments — with methodology, metrics, and deployment logic.
How consulting, staffing, and accounting firms reprice services when AI agents deliver the work — a practical methodology for the transition.
How to classify AI agent escalation triggers: which issues go to the board vs. management, with a governance framework for enterprise teams.
A five-stage maturity model mapping AI agent governance from ad-hoc experimentation to institutionalized control—with board-level risk frameworks.
A governance framework for holding companies deploying AI agents across portfolio subsidiaries—structure, oversight, and operational control.
Autonomous agents are compressing marketplace take rates by replacing human intermediaries. Discover how agent deployment reshapes cost structures and pricing
How to structure orchestration, foundation model, and deployment partner contracts into a coherent multi-vendor agent procurement without liability gaps or
Independent directors can build AI agent literacy without coding. A practical governance framework for boards navigating autonomous systems.
Learn how to structure an RFP for agentic systems that captures what traditional software procurement frameworks consistently miss.